The aim of Clinical Pharmacogenomics Group is to personalise medicine by studying DNA variations to better target a drug, or its dose, to improve health and prevent toxic reactions.
Pharmacogenomics is the study of variations in our genome (DNA and RNA) that alter our response to medicines and contribute to adverse drug reactions, and also how these genetic variations can be translated into clinical practice to provide a ‘precision medicine’ approach.
The Clinical Pharmacogenomics Group investigates genetic variants that impact on drug responses and a person’s immune response to drugs. We use various approaches, including pharmacokinetics, metabolism, pharmacodynamics (such as receptors and signalling messengers) and immune markers of drug hypersensitivity reactions.
Our studies look at drug metabolism and response (across cancer, addiction, solid-organ transplantation outcomes), neurogastroenterology and molecular toxicity (via a chemotherapy-induced model of mucositis), drug abuse and addiction (including alcohol, opioid and behavioural), pain (such as chronic pain in spinal cord injury and fibromyalgia), gulf-war illness and epilepsy.
Our large research program investigates pharmacogenomics of Aboriginal Australians. Discovery of interethnic differences in drug response and the genetic factors that contribute to such differences are of importance for drug and dosing guidelines.
Lead researcher: Professor Andrew Somogyi
- Professor Lisa Jamieson - Adelaide Dental School
- Professor Pal Klepstad - Norwegian University of Science and Technology, Trondheim, Norway
- Associate Professor Michal Kluger - University of New Zealand
- Professor Colleen Loo - University of New South Wales
- Associate Professor Paul Pumuye - University of Papua New Guinea
- Professor Alex Sia - KK Women’s and Children’s Hospital, Singapore
We offer exciting opportunities for researchers at the honours, masters and PhD levels. Our research degrees are open to students from a broad range of backgrounds, and range from basic sciences to clinical research. If you are interested in human health, consider furthering your research career with us.